Indian Pharma Market - Nov 2015 Highlights

December 31, 2015

Indian Pharma Market - Nov 2015 Highlights

Indian Pharma Market (IPM) clocked 7954 Crs and grew at 8.6%

Top Performers

Cipla grew by 15.8%, Alkem* by 9.2% and Macleods by 8.5% among top 10
23 Cos crossed the growth of IPM among top 50
Bharat Serums has the highest growth of 59.3% followed by Wockhardt at 38.3% & Hetero at 23.1% in the top 50
20 Cos showed more than 10% growth among the top 50
Alembic has the highest growth of 18.8% followed by Intas at 16.3% & DRL at 12.6% in the top 11 to 20
MSD* had the highest growth with 18.3% and Cadila 17.6% in the top 20 to 30
Blue Cross and JBCPL grew at 15.7% in the top 31-40
Hetero has the highest growth at 23.1% followed by Troikaa at 17.8% & Janssen at 11.2% in the 41-50
Boehringer grew at 51.3% followed by Eli Lilly at 34.9% & Centaur at 28.8% in the top 51-60
Fresenius Kabi grew at 69.5% followed by RPG at 13.7% in the top 61-70 Corporate,

Indian V/S MNCs

Indian cos grew at 9.1% Vs. 7.0% for MNCs in November 2015
MSD* grew by 18.3% followed by AstraZeneca by 13.1% & Janssen at 11.2% in the top 50 in MNCs
In the Non-NLEM category Indian Cos grew at 9.9% Vs. MNCs grew at 7.2%

DPCO, Non DPCO & Non-Scheduled Para 19 Market

DPCO containing molecules market grew at 4.8% whereas the non DPCO market grew by 9.3% and Non-Sch Para 19 Market at 6.8% resulting in an overall growth of 8.6% for November 2015

NLEM & Non - NLEM Category showed unit growth at 0.3% and 1.1% respectively. The Non-Sch Para 19 Market grew at 2.2% from unit perspective

Therapy Areas

10 therapy areas outgrew the IPM growth
Respiratory Market grew at 12.9%, Gastrointestinal market grew at 9.8% , Pain & Analgesics market grew at 8.9% whereas Anti-infectives grew at 7.2%
Anti-diabetic market grew at 16.1% & Cardiac at 8.2% in Chronic Business
Derma market grew by 7.9% & Urology Market at 8.3%
Gastrointestinal Market crosses 11k Crs and moves fast to get close to the Cardiac Market Value

Regional Dynamics:

From regional perspective 13 regions have outgrown the IPM growth
South AP market grew the highest at 22.6% followed by Odisha market at 21.4% & Jharkhand Market at 19.8%
6 regions had negative growth in November 2015

Molecules:

Amoxycillin + Clavulanic Acid & Glimepiride + Metformin Market grew at 9.7%

Paracetamol grew at 27.2%, Atorvastatin 1.9%, Probiotic Microbes at 22.7%, Cefixime 3.5%, Pantoprazole 5.1%, Montelukast + Levocetrizine at 11.4%, Glimepiride + Metformin + Pioglitazone at 12.6%, Vitamin-D at 13.6%, Hydroquinone + Mometasone + Tretinoin at -21.6%, Voglibose + Metformin + Glimepiride at 29.9%, Rosuvastatin at 13.4%, Protein Supplements at 2.8%, Azithromycin at 13.1%, Calcium Carbonate + Vit D3 market at -2.5%

Brands

Mixtard leads the pack with 31 Crs followed by Corex at 30 Crs,
Spasmoproxyvon Plus at 28 Crs, Glycomet GP at 26 Crs for November 2015

Brands that gained ranks include Rotarix (+65), Zienam (+60), Meronem (+58), Betnesol (+49), Betnovate C (+40), Ultracet, Betnovate N (+25), Jalra M (+21), Spasmoproxyvon Plus, Calpol, Vertin (+20), Deriphyllin (+19), Budecort, Huminsulin, Galvus (+18), Rhoclone (+17), Panderm Plus, Istamet, Omez, Mucaine (+16), Monocef-O, Trajent (+15), Rantac (+14), Sinarest, Foracort, Aciloc, Januvia, Dolo (+12), amongst top 100 Brands over November -14

Caripill becomes a 12 Cr Brand in a period of 5 months

Brands that have moved up ranks fastest into Top 300 Brands for the month of November - 15 are Revital H, Havrix, Hucog HP, Imicrit, Plavix, Grafeel, Ocid, Pradaxa

Quadriderm RF from MSD* is the 300th Biggest Brand and Revital H is the 200th Biggest Brand in IPM

New Launches in IPM:

303 Brands & 572 SKUs were launched in November 2015
Top New Brands for November -15 are Tenepride, Accura, Hertraz
4 Teneligliptin Brands launched in Nov -15 - Tenepride, Tenglyn, Dynaglipt & Tenuvia. Lupin enters the Linagliptin Market with Ondero

Biggest New Launch by an MNC is Hertraz in November 2015

Source: AIOCD Pharmasofttech AWACS